Intercept Pharmaceuticals, Inc. carries a market capitalization of 794.69M, placing it among publicly traded companies globally.
| Market Cap | 794.69M |
| Enterprise Value | N/A |
Intercept Pharmaceuticals, Inc.'s stock has gained approximately 35.81129% over the past 52 weeks. The 50-day moving average sits at 15.66, while the 200-day moving average is 14.71.
| Beta (5Y) | N/A |
| 52-Week Price Change | 35.81129% |
| 50-Day Moving Average | 15.66 |
| 200-Day Moving Average | 14.71 |
| Average Volume (20 Days) | N/A |